Small RNA, big impact 27.04.2023 Bioinformatics specialists explore the molecular mechanisms of ageing
World Day for Laboratory Animals and Alternative Models 21.04.2023 Reducing the number of animal studies
Bacterial weapons against viral diseases 20.03.2023 Discovery of two novel classes of natural products with activity against RNA viruses
HDDC 2023 - International Helmholtz Drug Discovery Conference 22.02.2023 Attracting a high-level audience of researchers, the conference will provide a stimulating platform to discuss the state of the art in drug discovery with academic experts and…
HIPS and CISPA join forces to make future active ingredients safer 15.02.2023 Helmholtz Association funds interdisciplinary collaboration between two of its Research Fields
New cell model for the human lung 08.02.2023 A research team from Saarbrücken develops a novel lung cell line for testing drugs
ERC Proof of Concept Grant for Anna Hirsch 24.01.2023 HIPS scientist receives funding to develop new antibiotics
Disarming pathogens: New drug candidates to combat chronic infections 23.01.2023 Saarbrücken researchers use bacterial communication as a target for new drugs
Sugar-based inhibitors disarm the pathogen Pseudomonas aeruginosa 16.01.2023 Researchers from Saarbrücken and Freiburg develop promising active ingredient to combat multi-resistant bacteria.
Using optimised natural products against difficult pathogens 13.01.2023 Improved darobactin derivatives show activity against carbapenem-resistant hospital germs
Saarbrücken antibiotics project funded by INCATE incubator 10.01.2023 New class of active agents to combat multi-resistant pathogens to be developed to market maturity in the coming years
New natural product against hospital germs 23.12.2022 Corramycin is a new compound with activity against Gram-negative pathogens
EU funds graduate school for drug research 06.12.2022 Over the next five years, 15 international doctoral students will be trained at Saarland University and HIPS.
World Antimicrobial Awareness Week 2022 18.11.2022 Antimicrobial resistance (AMR) is becoming an increasing threat to human health. It is estimated that nearly 1.3 million deaths were caused by resistant bacteria in 2019. To…
GO-Bio initial funding for two natural product projects at the HZI 28.09.2022 In the concept phase, scientists develop implementation strategies for metabolites from fungi and a new class of active substances against malaria
New junior research group in bioinformatics at HIPS 23.09.2022 We are very happy to welcome Alexey and his team at HIPS.
The HIPS project "The Microbial Treasure Chest" is shown on the MS Wissenschaft in Saarbrücken 18.07.2022 The floating Science Center will be anchored in Saarbrücken (near the Congresshalle in Bürgerpark) from August 5 to 8.
Research into antiviral agents 12.07.2022 Researchers from Saarland receive millions in funding from Volkswagen Foundation
Introducing Fabian Kern’s Junior Research Group 11.07.2022 We warmly welcome Fabian and his team to HIPS.
Portrait: From Odessa to Saarbrücken 08.07.2022 Pharmacist Mariia Nesterkina built a fast-track career in Odessa. She has since had to flee the war, swapping her lab in Ukraine for a life in Saarland where she continues to…
Two bugs with one stone 16.06.2022 Saarbrücken researchers optimize drug candidate against multi-resistant bacteria and parasites
Bioinformaticians decode protein that can reverse declining cognitive performance in old age 18.05.2022 New junior research group on single cell research at HIPS cooperates with Saarland University and Stanford University
Pathway in a tube 22.03.2022 HIPS scientists elucidate the biosynthesis of natural product Thioholgamide
Terrapeutics and HIPS sign cooperation agreement for the joint development of novel bioactive compounds 16.03.2022 Jerusalem, March 16 2022 - Terrapeutics Pharma (“Terrapeutics”) and the Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) are pleased to announce that they have…
New junior research group at HIPS 01.03.2022 We are delighted to welcome Julian Hegemann and his team at the HIPS.
Spin-off project Myxobiotics gains support from new incubator INCATE 06.02.2022 HZI and HIPS start-up develops new class of antibiotics
Cease-fire for resistant germs 14.12.2021 Saarbrücken researchers develop drug candidates against hospital germs
Assessing Bacterial Bioavailability / Are we there yet? 09.12.2021 Scientists at HIPS develop a screening tool for assessing bacterial bioavailability.
And the “Oscar of Pharmacy” goes to… 18.11.2021 Claus-Michael Lehr wins the PHOENIX Pharmacy Science Award 2021
From basic research to the clinic: new centre strengthens drug research in Saarland 30.09.2021 It often takes many years before a new active compound from basic research hits the market as a drug. In order to accelerate this process, the Helmholtz Institute for…
So long, Farewell Team Gregor 23.09.2021 After five years as a junior professor at HIPS, Gregor Fuhrmann will take up a professorship in pharmaceutical biology at the Friedrich-Alexander-University Erlangen-Nuremberg…
Want some more? 31.08.2021 Researchers from the Department of Microbial Natural Products improve the production of a new drug candidate.
Fighting resistances: Concepts for new antibiotics 20.08.2021 International research alliance proposes strategy for the discovery and development of new active substances
Claus-Michael Lehr selected as a scout in the Henriette Herz-Programme 02.08.2021 The Alexander von Humboldt Foundation has selected Claus-Michael Lehr as a scout within the Henriette-Herz-Programme.This award allows him to select three young scientific…
Hans-and-Ruth-Giessen-Scholarship for Chantal Bader 08.07.2021 Chantal Bader, postdoc in the Department of Microbial Natural Products, has been awarded a grant from the Hans-and-Ruth-Giessen-Foundation on 29 June 2021. As a talented young…
World Tuberculosis Day 2021: New drugs for old bugs 24.03.2021 On the occasion of World Tuberculosis Day, Jennifer Herrmann, scientist in the department Microbial Natural Products, talks about the epidemiology of the disease and her…
Putting pathogens on mute 19.03.2021 Saarbrücken researchers develop novel strategy for treating hospital germs
Deep insights into cystobactamid biosynthesis 10.03.2021 Scientists from the Microbial Natural Products department reveal how myxobacteria produce antimicrobial compounds.
Exciting natural products from rare myxobacteria 18.02.2021 Scientists from the Department of Microbial Natural Products discover a new class of natural products in an unusual myxobacterial strain
Leibniz Prize for Rolf Müller 10.12.2020 HIPS Director receives most important research award in Germany
Federal government decides on million-euro funding for HIPS 01.12.2020 The Federal Budget Committee has assured the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) funding of 47 million euros for the further expansion of the…
Important step in fighting resistant bacteria 01.12.2020 Team of Prof Anna Hirsch receives 1.46 million Euros in funding
ERC Starting Grant awarded to Gregor Fuhrmann 06.10.2020 Gregor Fuhrmann and two other HZI scientists receive million-euro funding from the European Research Council
Saarland University appoints Alexander Titz as Professor for Organic and Pharmaceutical Chemistry 09.07.2020 HIPS research group leader develops drug candidates and diagnostics for bacterial infections
Biomedical research strengthened in Saarland through the new Leibniz Science Campus 29.06.2020 HIPS takes part in the “Living Therapeutic Materials” project
Mirror, mirror – New enzyme group converts amino acid into its mirror image 29.06.2020 HIPS researchers decipher a step in the biosynthesis of an antibiotically active natural product
EU funds training network for young researchers 25.06.2020 Anna K. H. Hirsch coordinates EU-funded training of new generation of researchers
To the site of action - in the nanotransporter 17.04.2020 Novel vehicles increase the efficiency of antibiotics against chronic infections
Working together in the fight against tuberculosis and malaria 09.12.2019 Bill & Melinda Gates Foundation funds collaboration of the HZI/HIPS with Evotec to develop new drug approaches for treating tuberculosis and malaria
Pharmaceutical Research Alliance Saarland launched 29.11.2019 The Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Saarland University and the Leibniz Institute for New Materials enter into an interdisciplinary…
Anna Hirsch nominated for Young Chemist Award 09.09.2019 The European Federation of Medical Chemistry awarded HIPS researcher Anna Hirsch the Runner-Up Prize as Young Medicinal Chemist in Academia 2019
Gregor Fuhrmann awarded Young Investigators Prize 05.09.2019 HIPS researcher Gregor Fuhrmann has received the Young Investigators Award of the Horst Böhme Foundation of the German Pharmaceutical Society
2023 ISAM Congress 26.08.2023 The Congress aspires to bring together over 250 attendees at one of the world’s largest pulmonary drug delivery and respiratory health conferences. The ISAM attendees include…